{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-26-000024","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.621930+00:00","generated_at":"2026-05-15T15:31:00.632949+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elevance Health reaffirms FY2026 adj. EPS at least $25.50, benefit expense ratio ~90.2%","bullets":["Reaffirms adjusted shareholders' earnings for FY2026 at least $25.50 per diluted share.","Reaffirms 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.","Guidance includes impact of potential CMS sanctions suspending Medicare Advantage enrollment effective March 31, 2026 if not resolved.","Company cannot provide GAAP reconciliation due to uncertainty over financial payments to resolve CMS matter."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-26-000024","json":"https://secwatch.observer/filing/0001156039-26-000024.json","markdown":"https://secwatch.observer/filing/0001156039-26-000024.md","text":"https://secwatch.observer/filing/0001156039-26-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/0001156039-26-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000024/elv-20260310.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T15:31:00.632949+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}